The goal of the study is to determine the pharmacokinetic profile of the omeprazole component of PA8140 tablets and compare it to that of PA32540 tablets.
http://www.businesswire.com/news/topix/20131223005106/en
http://www.businesswire.com/news/topix/20131223005106/en
No comments:
Post a Comment